Danaher Corporation

Impact: As a major company in the CLIA market, Danaher Corporation is strengthening its market position through innovation and strategic collaborations, with its Danaher Corporation — Beckman Coulter DxI systems playing a major role in advancing high-throughput immunodiagnostic testing globally.

Impact: Danaher Corporation, as the parent company of Danaher Corporation — Beckman Coulter, benefits from the CE mark approval of the Access MeMed BV assay, which expands its diagnostics portfolio and market reach in Europe.

Impact: Danaher Corporation is listed among the top companies in the epigenetics market, suggesting its role in the industry.

Impact: Danaher Corporation is acquiring Masimo, which is under investigation by Halper Sadeh LLC.

Impact: Danaher Corporation announced a collaboration to enhance life science lab connectivity by integrating automated imaging and detection systems into research workflows through its operating company Molecular Devices, LLC.

Impact: Danaher Corporation is mentioned as another big U.S. life-science company that has made multibillion-dollar acquisitions, indicating a trend in the industry that Merck Group is following.